z-logo
open-access-imgOpen Access
Hemodiafiltration and High-Flux Hemodialysis Significantly Reduce Serum Valproate Levels Inducing Epileptic Seizures: Case Report
Author(s) -
Jakob Gubenšek,
Jadranka ButurovićPonikvar,
Rafael Ponikvar,
Boštjan Čebular
Publication year - 2008
Publication title -
blood purification
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 57
eISSN - 1421-9735
pISSN - 0253-5068
DOI - 10.1159/000135677
Subject(s) - hemodialysis , medicine , epilepsy , anticonvulsant , anesthesia , psychiatry
cally appearing after her HD sessions. At that time she was treated with postdilutional HDF, with 20 l infusate per 4.5-hour session, FX80 dialyzer (helixone, 1.8 m 2 , Fresenius Medical Care, Bad Homburg, Germany), blood flow 300 ml/min, AVF as vascular access. Valproate concentrations were measured before and after HDF approximately every 2 weeks and were 666 8 53 (range 567–750, therapeutic levels 345– 690)  mol/l before and 341 8 63 (range 261–462) mol/l after HDF, which represents a 49 8 9% (range 38–59%) decrease Sir, Valproate is used in the treatment of some forms of epilepsy. A recent review of antiepileptic drugs in patients with kidney disease [1] reports that dose supplementation after hemodialysis (HD) is not routinely recommended. It refers to some rather old literature, reporting that (lowefficiency) dialysis removes only 20% of administered valproate dose [2] and that (low-efficiency) HD (combined with hemoperfusion) produces only a transient drop in valproate concentration [3] . A significant removal of valproate with (highefficiency) HD has been reported in recent years, but only in cases of valproate intoxication at serum concentrations up to 10 times therapeutic levels [4, 5] . The previously mentioned review therefore remarks that the effect of high-efficiency HD on clearance and seizure activity in patients on chronic HD is not known. We report a case of a 23-year-old female HD patient (dry weight 57 kg, primary renal disease focal segmental glomerulosclerosis) who has been on HD for 3 years. She has had epilepsy since the age of 5 years and was treated with entericcoated valproic acid (Apilepsin ) 1,500– 1,800 mg on the non-dialysis day, with an additional 150–300 mg on the dialysis day – taken before or during HD. As hemodiafiltration (HDF) was introduced in our center in 2006, she began to experience short partial complex seizures typiPublished online: June 4, 2008

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom